Popular Articles

MDRNA, Inc. Receives Full FDA Approval Of Generic Calcitonin-Salmon Nasal Spray For Osteoporosis
MDRNA, Inc. (NASDAQ: MRNA) announced that it has obtained full U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for generic calcitonin-salmon nasal spray for the treatment of osteoporosis and that Par Pharmaceutical Companies, Inc. (NYSE: PAR) has launched the product.
generic viagra
House Democrats To Unveil Health Care Bill Details
"After a series of false starts, House Democrats are finally expected to unveil the details of a sweeping reform measure on Tuesday that would drastically revamp the country"s health care system," Politico reports. "Party leaders had initially planned to introduce legislation last week and start considering it in committees this week. But that timeline was scuttled when a parade of moderates threw up their arms last week at a draft of the bill offered weeks earlier by the three chairmen writing it." While the Democrats "know that the clock is ticking-that the slower the process goes, the more time opponents will have to plant doubts in the minds of voters," Republicans are "feeling giddy-free to stand back and watch as Democrats fight amongst themselves."
Zubni implantati
News of the day
One Of ASCO's Sleeper Hits: OGX-011 Cuts Provenge's Death Rate In Half
OGX-011 survival benefit: an even better Hazard Ratio.
Public Health

North American Launch For Revolutionary DrainPRO™ Protects Against Hospital & Community Acquired Infections

LAMAL USA today announced the long-awaited North American launch of DrainPRO™ at the Association for Professionals in Infection Control and Epidemiology (APIC) conference in Fort Lauderdale, June 8th. A patented, antimicrobial-infused drain insert, DrainPRO™ blocks infection causing bacteria, odors and insects from entering health care and other clean environments. "We"ve been waiting a long time for an infection control product as simple and effective as DrainPRO™" said Bernie Lyons, National Risk and Quality Manager with Healthe Care Australia in Sydney. "Drain openings are bacteria hot spots. With the skyrocketing frequency of hospital acquired infections, we have to be sure we"re sanitizing every single infection including drains - especially drains." Lawrence Evans, DrainPRO"s Australian designer added: "Drain openings are a breeding ground for deadly superbugs like MRSA and are a of foul odors. I designed DrainPRO to seal drains while maximizing water flow. The units are infused with MicrobePRO™ antimicrobial agent and have been tested and certified to be 99.99% effective against a comprehensive range of bacteria." Since 2007 when the deaths of 6 babies in a Canadian hospital were blamed on Pseudomonas aeruginosa in drainsÂð, infection control experts have struggled with the problem of sanitizing hospital drains. Harsh chemicals provide a temporary fix but are harmful to the environment. Sealing drains AND killing bacteria without blocking full water flow was Evans" design goal. The result, his patented DrainPRO™, is now being used in Australian hospitals. DrainPRO™ is part of the MicrobePRO™ suite of infection control solutions manufactured and distributed by LAMAL Group Pty Ltd. headquartered in Brisbane, Australia. Âð Reuters Health eLine - 2007-04-27 LAMAL USA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):